Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application
into routine care remains limited. Opportunely, several implementation studies and …

This commentary focuses on challenges to the widespread adoption of pharmacogenomics,
outlining issues that need to be addressed ranging from basic pharmacogenomics research …

Pharmacogenomic (PGx) testing is gaining recognition from physicians, pharmacists and
patients as a tool for evidence-based medication management. However, seemingly similar …

Background The clinical implementation of pharmacogenomics (PGx) could be one of the
first milestones towards realizing personalized medicine in routine care. However, its …

Purpose Due to the diversity within Europe, the implementation of pharmacogenomic testing
in clinical practice faces specific challenges. In the context of the European …

Considerable efforts have been exerted to implement Pharmacogenomics (PGx), the study
of interindividual variations in DNA sequence related to drug response, into routine clinical …

Abstract Background Pharmacogenetics (PGx) is currently implemented in hospitals to
optimize therapy with high-risk drugs. However, many drugs with dosing recommendations …

The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …

Response to a drug often differs widely among individual patients. This variability is
frequently observed not only with respect to effective responses but also with adverse drug …

The paradigm of individualized drug therapy based on genetics is an ideal that is now
potentially possible. However, translation of pharmacogenomics into practice has …